(Unaudited data)
- Cumulative activity as of the end of december 2014
| thousands of euros | 2013 | 2014 | Variation at current exchange rates | Variation at constant exchange rates |
| France | 346,965 | 343,891 | - 0.9% | - 0.9% |
| International : | 270,766 | 265,857 | - 1.8% | + 2.7% |
| Incl. Europe excluding France | 204,283 | 198,918 | - 2.6% | + 2.8% |
| Incl. North America | 53,364 | 52,813 | - 1.0% | + 0.3% |
| Incl. Other countries | 13,119 | 14,126 | + 7.7% | + 9.6% |
| Group Total | 617,731 | 609,748 | - 1.3% | + 0.7% |
| thousands of euros | 2013 | 2014 | Variation at current exchange rates | Variation at constant exchange rates |
| Non-proprietary Homeopathic Medicines | 305,739 | 305,501 | - 0.1% | + 0.0% |
| OTC Specialties | 311,581 | 303,549 | - 2.6% | + 1.2% |
| Other | 411 | 698 | + 69.8% | + 67.6% |
| Group Total | 617,731 | 609,748 | - 1.3% | + 0.7% |
- Quarterly activity in 2014 ( variation at current rate)
| 1 st Quarter | 2 nd Quarter | 3 rd Quarter | 4 th Quarter | |||||||||
| thousands of euros | 2013 | 2014 | Var. 14/13 | 2013 | 2014 | Var. 14/13 | 2013 | 2014 | Var. 14/13 | 2013 | 2014 | Var. 14/13 |
| France | 84,270 | 82,749 | - 1.8% | 75,327 | 74,269 | - 1.4% | 92,596 | 92,466 | - 0.1% | 94,772 | 94,407 | - 0.4% |
| International : | 73,751 | 57,460 | -22.1% | 42,436 | 47,138 | +11.1% | 76,890 | 79,646 | +3.6% | 77,689 | 81,613 | +5.1% |
| Incl.Europe excluding France | 54,334 | 39,967 | - 26.4% | 29,047 | 33,570 | + 15.6% | 61,256 | 62,758 | + 2.5% | 59,646 | 62,623 | +5.0% |
| Incl. North America | 15,562 | 12,662 | - 18.6% | 10,017 | 10,625 | + 6.1% | 12,153 | 13,109 | + 7.9% | 15,632 | 16,417 | +5.0% |
| Incl. Other countries | 3,855 | 4,831 | +25.3% | 3,372 | 2,943 | - 12.7% | 3,481 | 3,779 | + 8.6% | 2,411 | 2,573 | +6.7% |
| Group Total | 158,021 | 140,209 | -11.3% | 117,763 | 121,407 | + 3.1% | 169,486 | 172,112 | +1.5% | 172,461 | 176,020 | +2.1% |
| 1 st Quarter | 2 nd Quarter | 3 rd Quarter | 4 th Quarter | |||||||||
| thousands of euros | 2013 | 2014 | Var. 14/13 | 2013 | 2014 | Var. 14/13 | 2013 | 2014 | Var. 14/13 | 2013 | 2014 | Var. 14/13 |
| Non-proprietary Homeopathic Medicines | 79,062 | 77,919 | - 1.4% | 73,035 | 73,072 | + 0.1% | 73,597 | 72,957 | - 0.9% | 80,045 | 81,553 | + 1.9% |
| OTC Specialties | 78,866 | 62,196 | -21.1% | 44,600 | 48,058 | + 7.8% | 95,813 | 99,025 | + 3.4% | 92,302 | 94,270 | + 2.1% |
| Other | 93 | 94 | +1.1% | 128 | 277 | +116.4% | 76 | 130 | +71.1% | 114 | 197 | +72.8% |
| Group Total | 158,021 | 140,209 | -11.3% | 117,763 | 121,407 | + 3.1% | 169,486 | 172,112 | + 1.5% | 172,461 | 176,020 | + 2.1% |
Highlights of the fourth quarter
- Sales revenue in the fourth quarter of 2014 grew by 2.1% (5.1% at constant rate).
- Given the evolution of business and the control of costs, the 2014 operating income should grow in comparison to 2013.
- On December 31, 2013, the group's net cash position is close to 156 million euros.
On January 19, 2015 , the Superior Court of Montreal rejected the complaint aiming at launching a class action proceeding filed on April 13, 2012.
Our next update: March 18, 2015, after the close of the stock market, publication of 2014 results.
Financial information manager: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: finances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at : www.boironfinance.com
Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-38559-BOI-220115-CA-14-GB.pdf
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer